Subscribe
shutterstock_326305964_everything_possible
everything possible / Shutterstock.com
16 March 2021Big PharmaMuireann Bolger

Medical tech leads 2020 innovation at the EPO

Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
Why did a South Korea court invoke the ‘extraterritorial activity’ exception in Prevenar 13 case?
12 December 2023   A Korean district court has applied a landmark ruling in a complicated vaccine dispute involving Pfizer, explain Young Kim, Yu-Seog WON, In Hwan Kim, and Amy Oh of Kim & Chang.
Europe
Pharma patent filings rise at EPO amid pandemic
5 April 2022   Patent applications in Europe reached record levels during 2021 amid the COVID-19 pandemic, according to a new report by the European Patent Office.
Europe
EPO launches Unitary Patent dashboard revealing daily take-up figures
25 July 2023   Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Europe
EPO launches Unitary Patent dashboard revealing daily take-up figures
25 July 2023   Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.
Europe
Pharma patent filings rise at EPO amid pandemic
5 April 2022   Patent applications in Europe reached record levels during 2021 amid the COVID-19 pandemic, according to a new report by the European Patent Office.
Asia
Why did a South Korea court invoke the ‘extraterritorial activity’ exception in Prevenar 13 case?
12 December 2023   A Korean district court has applied a landmark ruling in a complicated vaccine dispute involving Pfizer, explain Young Kim, Yu-Seog WON, In Hwan Kim, and Amy Oh of Kim & Chang.

More on this story

Europe
EPO launches Unitary Patent dashboard revealing daily take-up figures
25 July 2023   Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.
Europe
Pharma patent filings rise at EPO amid pandemic
5 April 2022   Patent applications in Europe reached record levels during 2021 amid the COVID-19 pandemic, according to a new report by the European Patent Office.
Asia
Why did a South Korea court invoke the ‘extraterritorial activity’ exception in Prevenar 13 case?
12 December 2023   A Korean district court has applied a landmark ruling in a complicated vaccine dispute involving Pfizer, explain Young Kim, Yu-Seog WON, In Hwan Kim, and Amy Oh of Kim & Chang.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York